[go: up one dir, main page]

AR087463A1 - Cepa de l. bulgaricus con capacidad para inhibir la adhesion de cepas de h. pylori a celulas epiteliales - Google Patents

Cepa de l. bulgaricus con capacidad para inhibir la adhesion de cepas de h. pylori a celulas epiteliales

Info

Publication number
AR087463A1
AR087463A1 ARP120102859A ARP120102859A AR087463A1 AR 087463 A1 AR087463 A1 AR 087463A1 AR P120102859 A ARP120102859 A AR P120102859A AR P120102859 A ARP120102859 A AR P120102859A AR 087463 A1 AR087463 A1 AR 087463A1
Authority
AR
Argentina
Prior art keywords
bulgaricus
pylori
cepa
bloods
inhibit
Prior art date
Application number
ARP120102859A
Other languages
English (en)
Inventor
Peggy Garault
Gaelle Quere
Raphaelle Bourdet-Sicard
Francis Megraud
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of AR087463A1 publication Critical patent/AR087463A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1238—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/123—Bulgaricus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

El presente se refiere a una cepa de Lactobacillus delbrueckii, subsp. bulgaricus, adecuada para la utilización en el tratamiento o la prevención de la infección por parte de Helicobacter pylori. Método para obtener la cepa.
ARP120102859A 2011-08-09 2012-08-03 Cepa de l. bulgaricus con capacidad para inhibir la adhesion de cepas de h. pylori a celulas epiteliales AR087463A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2011/053552 WO2013021239A1 (en) 2011-08-09 2011-08-09 New strain of l. bulgaricus capable of inhibiting the adhesion of h. pylori strains to epithelial cells

Publications (1)

Publication Number Publication Date
AR087463A1 true AR087463A1 (es) 2014-03-26

Family

ID=44645757

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120102859A AR087463A1 (es) 2011-08-09 2012-08-03 Cepa de l. bulgaricus con capacidad para inhibir la adhesion de cepas de h. pylori a celulas epiteliales

Country Status (10)

Country Link
US (1) US9272007B2 (es)
EP (1) EP2742125B1 (es)
JP (1) JP5997769B2 (es)
CN (1) CN103987839B (es)
AR (1) AR087463A1 (es)
BR (1) BR112014002911B1 (es)
ES (1) ES2627767T3 (es)
MX (1) MX350212B (es)
RU (1) RU2584600C2 (es)
WO (1) WO2013021239A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925225B2 (en) 2014-09-26 2018-03-27 Nubiome, Inc. Treatment and prophylaxis for gastroesophageal reflux disease
AU2017259987B2 (en) 2016-05-03 2023-10-19 Sqz Biotechnologies Company Intracellular delivery of biomolecules to induce tolerance
CN111118106B (zh) * 2019-12-20 2021-12-17 善恩康生物科技（苏州）有限公司 一株可以抑制幽门螺旋杆菌的嗜酸乳杆菌la-10a及其应用
CN116024129B (zh) * 2022-11-29 2024-09-24 光明乳业股份有限公司 一株能够与幽门螺杆菌共聚集的卷曲乳杆菌及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1148064A1 (en) * 2000-04-17 2001-10-24 Vrije Universiteit Brussel Lactobacillus johnsonii bacteriocin, active against Helicobacter pylori
CN101314763B (zh) * 2007-06-01 2011-06-08 统一企业(中国)投资有限公司 具有抗胃肠道致病菌、抗氧化和降血压作用的短双歧杆菌及其用途
JP5679255B2 (ja) * 2009-12-28 2015-03-04 株式会社明治 酸素耐性が増強された微生物およびその利用

Also Published As

Publication number Publication date
WO2013021239A1 (en) 2013-02-14
ES2627767T3 (es) 2017-07-31
BR112014002911A2 (pt) 2017-03-01
MX2014001572A (es) 2015-03-05
CN103987839A (zh) 2014-08-13
BR112014002911B1 (pt) 2020-12-08
RU2014108605A (ru) 2015-09-20
US20140205571A1 (en) 2014-07-24
EP2742125B1 (en) 2017-03-15
RU2584600C2 (ru) 2016-05-20
US9272007B2 (en) 2016-03-01
CN103987839B (zh) 2016-11-23
JP5997769B2 (ja) 2016-09-28
JP2014522667A (ja) 2014-09-08
MX350212B (es) 2017-08-30
EP2742125A1 (en) 2014-06-18

Similar Documents

Publication Publication Date Title
EP3011079B8 (en) Method to produce metal matrix nanocomposite with graphene, graphene oxide, metal oxide or metal nitride
HK1220326A1 (zh) 基於网络微生物组成和方法
WO2016054520A3 (en) Engineered cell surface proteins and uses thereof
HUE043338T2 (hu) Blautia hydrogenotrophica baktériumtörzset tartalmazó készítmények, a gyomor-bélrendszer bakteriális fertõzéseinek kezelésében történõ alkalmazásra
EP2665956A1 (en) Micro-pump or normally-off micro-valve
GB201122001D0 (en) Multiple orientation nanowires with gate stack stressors
AR094025A1 (es) Utilizacion de bifidobacterium animalis para el tratamiento o la prevencion de la ganancia de peso corporal y de la resistencia a la insulina
UA113059C2 (xx) Протимікробна композиція на основі штамів lactobacillus rhamnosus, lactobacillus paracasei
MX354859B (es) Uso de excipientes polimericos para liofilizacion o congelacion de particulas.
CL2013000430A1 (es) Metodo para proteger una planta contra un patógeno bacteriano, fúngico o viral porque comprende poner en contacto la planta con bismuto tiol (bt); metodo para superar la resistencia a antibioticos en una planta, en o sobre la cual está presente un patógeno vegetal bacteriano resistente a los antibioticos.
EP2928064A4 (en) ELASTIC BODY FOR ACTUATOR, AND PIEZOELECTRIC ACTUATOR
WO2012085652A3 (en) Methods for differentiating between disease states of mycobacterium tuberculosis infection
WO2016106343A8 (en) Probiotic organisms for diagnosis, monitoring, and treatment of inflammatory bowel disease
RU2011134931A (ru) Штамм enterococcus, используемый для приготовления кисломолочных напитков
RU2011135537A (ru) Штамм enterococcus hirae, используемый при производстве кисломолочных продуктов
MX342226B (es) Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio.
WO2009019320A3 (en) Method for inducing and accelerating cells
AR087463A1 (es) Cepa de l. bulgaricus con capacidad para inhibir la adhesion de cepas de h. pylori a celulas epiteliales
MX337027B (es) Dispositivo de almacenamiento.
BR112014015527A8 (pt) cepa de lactobacillus mucosae, método para a obtenção de uma cepa e de uma fração de célula, composição e método para a obtenção de uma composição
WO2014091182A3 (en) Muscle conditioning device
KR101468123B9 (ko) 탯줄 유래 줄기세포를 포함하는 근위축 질환 개선 또는 치료용 조성물
EP3063245A4 (en) Improved materials, treatment compositions,&material laminates, with carbon nanotubes
EP3149754A4 (en) Chip-scale embedded carbon nanotube electrochemical double layer supercapacitor
MX2020013361A (es) Cepas y metodos para el reparto de energia en rumiantes.

Legal Events

Date Code Title Description
FC Refusal